Olli Ritvos
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.
Journal: BMC infectious diseases
Published: November 21, 2025
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1.
Journal: Vaccine
Published: August 05, 2025
Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth.
Journal: American journal of physiology. Cell physiology
Published: July 07, 2025
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.
Journal: Frontiers in immunology
Published: September 10, 2024
Improved health by combining dietary restriction and promoting muscle growth in DNA repair-deficient progeroid mice.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 07, 2024
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection.
Journal: mBio
Published: February 20, 2024
Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin-desmin double knockout (DKO) mouse.
Journal: The Journal of physiology
Published: February 14, 2024
Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction-associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2024
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Journal: Nature communications
Published: December 22, 2022
Last Updated: 09/26/2026